Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Update on Tomudex® (raltitrexed) in the treatment of colorectal cancer
    Meeting Abstract

    Bertino, J. R.; Schwartz, G. K.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Gemcitabine and irinotecan in advanced gastrointestinal malignancies
    Meeting Abstract

    O'Reilly, E. M.; Schwartz, G. K.; Ilson, D. H.; Kemeny, N. K.; Saltz, L. B.; Kelsen, D. P.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • Development of CDK inhibitors for clinical cancer therapy
    Meeting Abstract

    Schwartz, G. K.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer
    Meeting Abstract

    O'Reilly, E.; Hammond, L.; Donehower, R.; Schwartz, G.; Kelvin, J.; Aird, S.; Sharma, S.; Schrag, D.; Molloy, K.; De Jager, R.
    Annals of Oncology (2000)

    Fulltext@MSK | Save
  • Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells
    Journal Article

    Li, X. K.; Motwani, M.; Tong, W.; Bornmann, W.; Schwartz, G. K.
    Molecular Pharmacology (2000)

    Fulltext@MSK | Save
  • The relevance of drug sequence in combination chemotherapy
    Journal Article

    Shah, M. A.; Schwartz, G. K.
    Drug Resistance Updates (2000)

    Fulltext@MSK | Save
  • Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development
    Journal Article

    Kaubisch, A.; Schwartz, G. K.
    The Cancer Journal (2000)

    Fulltext@MSK | Save
  • The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow
    Journal Article

    Koutcher, J. A.; Motwani, M.; Zakian, K. L.; Li, X. K.; Matei, C.; Dyke, J. P.; Ballon, D.; Yoo, H. H.; Schwartz, G. K.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells
    Journal Article

    Motwani, M.; Li, X. K.; Schwartz, G. K.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
    Journal Article

    Hsueh, C. T.; Chiu, C. F.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save